In 2017, the global metagenomics market was valued at USD 409.26 billion. The market is expected to be driven by investments in bioinformatics platforms that support metagenomics and microbiome profiling. Researchers are becoming more interested in new research areas like metatranscriptomics and metaproteomics. This has encouraged microbiologists explore the potential workflows.
The scope of metagenome analysis is now more widely available and the diversity of ecosystems that can be used has grown by multiple times in the past few years. The study of microbial consortia within a host has been possible thanks to rapid advances in genomic technology and ancillary protocols. This technology is expected to have significant market potential in many life science industries. The introduction of high-throughput sequencing technologies, such as the iSeq 100 System and MiniSeq System for amplicon sequence, has facilitated taxonomy and phylogeny studies of metagenomics samples.
As they support metagenomic lab workflows, bioinformatics companies play an important role in their growth. In collaboration with CosmosID, QIAGEN released metagenomic plug-ins in December 2018. Additionally, De Novo assembly and whole genome sequencing are available for simplified analysis. The declining cost of sequencing technology in recent years has led to an increase in their deployment.
Innovative conceptual and methodological tools, such as Integrated Microbial Genome/Microbiome, are used to speed up metagenomics-related workflows. This can help increase revenue generation. IMG/M can be used to analyze the functional capabilities of microbial communities, based on the sequence of the metagenome.
Researchers can now conduct 3D metagenomics studies thanks to bioinformatics programming advances. In February 2017, for example, researchers from Institut Pasteur carried out an experiment that used 3D structures of DNA fragments taken from the microbiota in mouse intestine to study interactions between phages and bacteria.
A metagenomics analysis of thousands more samples revealed that approximately 125,000 new viral genes had been discovered as of August 2016. The development of new metagenome study products is expected to be driven by the increasing number of viral genes and rising concerns about viral diseases like Hepatitis B, Hepatitis C and HIV/AIDS.
Numerous kits and reagents have been launched to meet the growing demand for library preparation workflows in research laboratories. Nextera XT Kit, NEXTflex16S V1-V3 amplicon-Seq kit, and NuGENOvation library preparation kits are some of the key products. This segment has a high market penetration and a higher usage rate.
To increase their market presence, players are focusing on providing library preparation kits that have improved compatibility and use the most recent sequencing technologies. Many new tools and software are being developed to help create microbiome data sets. This will allow for easier access to and greater availability of all genomic information. ICoVeR is an open-source software package that allows you to combine disparate genomic data.
Segment growth is expected to be driven by the increasing use of function-driven metagenomics in protein screening. This screening can be used to detect antibiotic resistance and produce vitamins. Function-driven technology also allows for the identification of proteins that are involved in the degradation of pollutants and the prediction of their degradation rates. It has been used to understand the in-situ biodegradation mechanism for organophosphorus compounds, and to predict its potential degradation.
Due to the higher adoption of sequencing technology, the sequencing-driven segment was the most lucrative in 2017. High adoption of this technology can be attributed to advent of novel bioinformatics-related solutions, which simplifies workflows and provides rapid results. To deliver fast results, it uses bioinformatics tools as well as computational analysis, such as MEGAN, METAREP and CAMERA. The sequence-driven technique segment will be driven by efforts to maintain a standard data base and increase in metagenome samples deposited at data repositories.
Metagenomics is widely used in environmental applications. The ability to screen uncultured microbes and the growing interest in microbiologists in microbes who live in extreme environments has driven this segment. The use of environmental applications in agriculture includes crop support, bioremediation via wastewater treatment, clean up of oil spillages, and biofuel production through the harnessing of microbial power.
The rapid growth in the number of studies that are being done to establish a link between microbes, human diseases and advanced sequencing technologies has been aided by the rapid advancement of these technologies. The American Human Microbiome Project (American Human Microbiome Project) and the European MetaHIT project (Metagenomics of Human Intestinal Tract), have helped in metagenome-based exploration of human intestinal microbiome by using reference gene catalogues. This is helping to grow the human health segment. The segment will also benefit from an increase in investments in similar studies related the human microbiome.
In 2017, North America was the dominant market in terms revenue. The dominance of North America in terms of revenue can be attributed to the existence of many prominent biotechnology companies that are focused on metagenomics workflows. CosmosID, for example, introduced the GENIUS metagenomics application in Illumina's BaseSpace Apps in May 2015. This can be used with NGS platforms.
Asia Pacific is expected see the most rapid growth over the forecast period due to ongoing developments in bioinformatics infrastructure and genomic landscapes in India and China. These methods will be more popular in the future due to significant differences in the climate and environment between Asian countries.
Illumina, Inc., Promega Corporation, Novogene Corporation, Oxford Gene Technology, Inc., Thermo Fisher Scientific, Inc., TAKARA BIO Inc., Danaher, QIAGEN, and ELITechGroup are some of the major players in this market.
To increase their market presence, and to improve their strategic partnerships with players in emerging markets, companies are actively seeking out acquisitions of these players. For instance, in March 2016, Diversigen-microbiome analysis service provider, entered into a collaboration with South Korea-based bioanalytical CRO-BioCore Co. Ltd. to expand its operations in the APAC region.
This report predicts revenue growth at the global, regional and country level and offers an analysis of industry trends in each sub-segment from 2014 to 2025. Grand View Research has divided the global metagenomics market report by product, technology, region, and application.
Product Outlook (Revenue USD Million, 2014-2025)
Kits and Reagents
Sequencing & Data Analytics Services
Other
Technology Outlook (Revenue USD Million, 2014-2025)
Sequencing Driven
Function-Driven
App Outlook (Revenue USD Million, 2014-2025)
Environmental
Human Health
Other
Regional Outlook (Revenue USD Million, 2014-2025)
North America
The U.S.
Canada
Europe
Germany
The U.K.
Asia Pacific
Japan
China
Latin America
Brazil
Middle East and Africa (MEA).
South Africa
b. Global metagenomics market was valued at USD 549.60 millions in 2019, and is projected to grow to USD 638.94 in 2020.
What is the growth rate of metagenomics?b. Global metagenomics is forecast to grow at a compound annual rate of 16.62% between 2018 and 2025, reaching USD 1,400.46 millions by 2025.
Which segment had the largest market share in metagenomics?b. The metagenomics market was dominated by the kits & reagents category with a share at 74.1% in 2019. This is due to the fact that a large number of kits and other reagents are currently being developed to meet growing demand for library preparation workflows in research laboratories.
What are the major players in metagenomics?b. Among the key players in the metagenomics market are Illumina, Inc., Promega Corporation, Novogene Corporation, Oxford Gene Technology, Inc., Thermo Fisher Scientific, Inc., TAKARA BIO Inc., Danaher, QIAGEN, and ELITechGroup.
What are the driving factors for the metagenomics industry?b. Market growth is driven by increasing interest in metatranscriptomics, Metaproteomics, and Metametabolomics; as well as rapid advances in genomic technologies & other protocols.
Up Market Research published a new report titled “Metagenomics Market research report which is segmented by Application (Environmental), by Technology (Function, Sequencing), by Product (Sequencing & Data Analytics), By Players/Companies Others, Sequencing & Data Analytics Services, Kits & Reagents, Product Outlook (Revenue USD Million 2014 - 2025)Kits & ReagentsSequencing & Data Analytics ServicesOthers”. As per the study the market is expected to grow at a CAGR of XX% in the forecast period.
Report Attributes | Report Details |
Report Title | Metagenomics Market Research Report |
By Application | Environmental |
By Technology | Function, Sequencing |
By Product | Sequencing & Data Analytics |
By Companies | Others, Sequencing & Data Analytics Services, Kits & Reagents, Product Outlook (Revenue USD Million 2014 - 2025)Kits & ReagentsSequencing & Data Analytics ServicesOthers |
Regions Covered | North America, Europe, APAC, Latin America, MEA |
Base Year | 2020 |
Historical Year | 2018 to 2019 (Data from 2010 can be provided as per availability) |
Forecast Year | 2028 |
Number of Pages | 203 |
Number of Tables & Figures | 143 |
Customization Available | Yes, the report can be customized as per your need. |
The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include products, applications, and competitor analysis.
The market is segmented by Application (Environmental), by Technology (Function, Sequencing), by Product (Sequencing & Data Analytics).
Metagenomics Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report.
Key Benefits for Industry Participants & Stakeholders:
Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa (MEA). North America region is further bifurcated into countries such as U.S., and Canada. The Europe region is further categorized into U.K., France, Germany, Italy, Spain, Russia, and Rest of Europe. Asia Pacific is further segmented into China, Japan, South Korea, India, Australia, South East Asia, and Rest of Asia Pacific. Latin America region is further segmented into Brazil, Mexico, and Rest of Latin America, and the MEA region is further divided into GCC, Turkey, South Africa, and Rest of MEA.
We have studied the Metagenomics Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2028.
How you may use our products:
Reasons to Purchase the Metagenomics Market Report:
Some other reports from this category!